U.S. Senate · 119th Congress · S. 4355
Drug Deal Disclosure Act
A bill to require the Department of Health and Human Services to release documents, communications, and other information relating to most favored nation pricing agreements and other private or confidential drug pricing deals struck with manufacturers, and for other purposes.
Follow
Log in to follow this bill and get an email when there’s a new vote (premium).
- Sponsor
- Ron WydenD-OR
- Introduced
- April 21, 2026, in the Senate
- Issue areas
- Policy area
- Health (from the Congressional Research Service)
- Full text and actions
- congress.gov
Votes on this bill (0)
Neither the House nor the Senate has held a roll-call vote on this bill.
Cosponsors (18)
18 Democrats. Each member is shown with the party they were counted with on the day they signed on. How we count these
Original cosponsors
- Tammy BaldwinD-WI
- Michael F. BennetD-CO
- Maria CantwellD-WA
- Catherine Cortez MastoD-NV
- Ruben GallegoD-AZ
- Margaret Wood HassanD-NH
- Mazie K. HironoD-HI
- Mark KellyD-AZ
- Ben Ray LujánD-NM
- Jeff MerkleyD-OR
- Bernard SandersD-VT
- Tina SmithD-MN
- Mark R. WarnerD-VA
- Raphael G. WarnockD-GA
- Elizabeth WarrenD-MA
- Peter WelchD-VT
- Sheldon WhitehouseD-RI
Signed on later
- Chris Van HollenD-MDApril 27, 2026